Drug or treatment

Zuberitamab clinical trials

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Pomalidomide with orelabrutinib and zuberitamab for newly diagnosed mantle cell lymphoma

  This study tests whether adding pomalidomide to orelabrutinib and zuberitamab helps people with untreated mantle cell lymphoma become minimal residual disease (MRD) negative after six treatment cycles.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07257510

• Combining Orelabrutinib and Zuberitamab for treating Marginal Zone Lymphoma

  This study is testing if combining two medications, Orelabrutinib and Zuberitamab, can help people with untreated Marginal Zone Lymphoma feel better and have fewer side effects.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT06985472

Quick answers

How many clinical trials of Zuberitamab are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →